REGN5713-5715

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN5713-5715, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy [Phase 3]

See pricing